Women In Bio Announces Jane Wasman Appointed Chair of Sellas Life Sciences’ Board of Directors
February 01 2018 - 4:01PM
Women In Bio (WIB), an organization of professionals committed to
promoting careers, leadership, and entrepreneurship of women in the
life sciences, announced today the appointment of another female
executive to a life sciences company board. Launched in 2016,
Boardroom Ready is Executive Women In Bio’s exclusive executive
development platform, designed to fuel women’s participation on
corporate boards in the life sciences.
WIB is delighted to announce that Jane Wasman, President,
International and General Counsel of Acorda Therapeutics, has been
appointed as Chair of the Board of Directors of Sellas Life
Sciences (NASDAQ:SLS). Sellas Life Sciences is a late-stage
biopharmaceutical company focused on the development of novel
immunotherapies for a broad range of cancer indications. Ms.
Wasman participated in WIB’s Boardroom Ready program in
2017.
“Boardroom Ready provides a strong platform for women to expand
their networks and maximize their opportunities to join company
boards. With research showing that board diversity correlates
with improved company results and increased shareholder value,
programs such as Boardroom Ready can benefit both individual women
executives and the companies whose boards they join.”
Ms. Wasman continued, “I am delighted to be working with my
fellow directors to support the team at Sellas as they
continue building on their progress in developing their novel
immunotherapy pipeline to address the unmet needs of patients
battling cancer.”
Ms. Wasman is a strategic leader with over 20 years in the
biopharmaceutical industry, including extensive U.S. and
international experience. An adaptable executive serving in both
C-suite and board of director chair roles, she has achieved success
in a range of settings, from large, public multinational companies
to privately held start-up companies. Her expertise includes
M&A, strategic development, corporate governance, litigation,
commercial, compliance and government affairs, as well as
operational implementation.
As President, International and General Counsel at Acorda
Therapeutics, Ms. Wasman leads long-range planning and development
in addition to international expansion. In this role, she
collaborates with senior leadership on commercialization,
licensing/M&A strategy and implementation, investor relations,
product pipeline development and government affairs activities. She
also built and manages Acorda’s legal, compliance, IP and quality
functions. Her department was recognized as one of four "Best Legal
Departments" nationally by Corporate Counsel in 2013.
In its third year, Boardroom Ready is a dynamic program aimed to
place executive women on corporate boards. “We are very
excited with the progress we have made in our first two
years. We have had multiple board placements, and the
momentum is with us,” remarks Carolyn Brougham, Chair of the
Boardroom Ready Program. “We are currently accepting
applications to the 2018 Boardroom Ready cohort. We look
forward to seeing another dynamic group of women join corporate
boards around the world.” For more information about the
Boardroom Ready program, please go to:
http://www.womeninbio.org/page/BoardroomReady.
Women In Bio (WIB) is an organization of
professionals committed to promoting careers, leadership, and
entrepreneurship of women in the life sciences. Each of its 13
chapters hosts numerous events throughout the year, including
networking, career development, professional education, and
executive level-focused events. WIB also hosts a mentorship program
which offers women the chance to mentor or be mentored, a Young
Women In Bio program, which offers events and encouragement to
middle-school aged girls, webinars, and the support of a large
national organization with 13 chapters and growing. As a volunteer
organization, WIB offers leadership opportunities at every stage of
your career, and a chance to expand your network in a supportive
and professional environment. For more information,
visit www.womeninbio.org.
Boardroom Ready - In its
third year, the Boardroom Ready Program is a cohesive program
designed to elevate, promote, and place highly qualified women to
corporate boards. Intensive board competency building
curriculum at George Washington University, held annually to refine
each candidate’s understanding of the duties, responsibilities, and
commitments related to serving on both public and private boards,
is only the beginning. Boardroom Ready candidates also work with a
professional resume writer to craft a board-tailored Curriculum
Vitæ and biography. In addition, each candidate is partnered
with an experienced board mentor to help navigate the path to board
service. Throughout the program and following completion,
WIB, LifeSci Advisors and other sponsors work to facilitate
matching program graduates with companies seeking new board
members. For more information regarding the Boardroom Ready
program, including cost, the selection process, and application
requirements, please
visit http://www.womeninbio.org/page/BoardroomReady.
Contact: Carolyn Brougham, Chair Boardroom Ready, Women In
BioE-mail: boardroomready@womeninbio.org
SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From Apr 2024 to May 2024
SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From May 2023 to May 2024